Barely Significant
← all excerpts

Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review.

Acta Derm Venereol · 2023 · PMC10525442 · PMID 37731213

1
hedged sentence
closest p
boldest claim

The sentences

might be significantno p-value reported
In addition, an ongoing, long-term extension trial ( NCT01500551 , https://classic.clinicaltrials.gov/ct2/show/NCT01500551?term=01500551&draw=2&rank=1 ) might be significant in observing the long-term safety of tofacitinib in paediatric patients.

also in 2,457 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.